Literature DB >> 1315044

Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products.

H N Antoniades1, T Galanopoulos, J Neville-Golden, C J O'Hara.   

Abstract

Lung cancer represents one of the major human carcinomas with the highest degree of mortality. Epidemiologic studies have linked this disease to "chronic injury," largely induced by cigarette smoking. In the present studies, we demonstrate the in vivo expression of platelet-derived growth factor (PDGF) and PDGF receptor (PDGF-R) beta mRNAs and their respective protein products in malignant epithelial cells of primary human lung carcinomas. In contrast, nonmalignant epithelial cells in control, normal lung tissue specimen did not express PDGF and PDGF-R mRNAs and did not produce their respective protein products. Epithelial cells in lung specimen from patients with idiopathic pulmonary fibrosis expressed only PDGF mRNA but not PDGF-R beta mRNA. These findings of the inappropriate coexpression of a potent mitogen, PDGF, and its receptor in lung cancer epithelial cells suggest the presence of a powerful in vivo mechanism contributing to the self-stimulation and unregulated growth of lung cancer tumor cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315044      PMCID: PMC525607          DOI: 10.1073/pnas.89.9.3942

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors.

Authors:  Y Yarden; J A Escobedo; W J Kuang; T L Yang-Feng; T O Daniel; P M Tremble; E Y Chen; M E Ando; R N Harkins; U Francke
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

2.  Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines.

Authors:  D A Bronzert; P Pantazis; H N Antoniades; A Kasid; N Davidson; R B Dickson; M E Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.

Authors:  S Rodenhuis; M L van de Wetering; W J Mooi; S G Evers; N van Zandwijk; J L Bos
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

4.  Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.

Authors:  K Saksela; J Bergh; V P Lehto; K Nilsson; K Alitalo
Journal:  Cancer Res       Date:  1985-04       Impact factor: 12.701

5.  v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer.

Authors:  M Mabry; T Nakagawa; B D Nelkin; E McDowell; M Gesell; J C Eggleston; R A Casero; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line.

Authors:  J P Falco; S B Baylin; R Lupu; M Borges; B D Nelkin; R K Jasti; N E Davidson; M Mabry
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  Amplification and expression of the c-myc oncogene in human lung cancer cell lines.

Authors:  C D Little; M M Nau; D N Carney; A F Gazdar; J D Minna
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

8.  Constitutive production of platelet-derived growth factor-like proteins by human prostate carcinoma cell lines.

Authors:  N M Sitaras; E Sariban; M Bravo; P Pantazis; H N Antoniades
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

9.  cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines.

Authors:  C Betsholtz; A Johnsson; C H Heldin; B Westermark; P Lind; M S Urdea; R Eddy; T B Shows; K Philpott; A L Mellor
Journal:  Nature       Date:  1986 Apr 24-30       Impact factor: 49.962

10.  Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types.

Authors:  C H Heldin; G Bäckström; A Ostman; A Hammacher; L Rönnstrand; K Rubin; M Nistér; B Westermark
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

View more
  23 in total

1.  Molecular Events as Targets of Anticancer Drug Therapy.

Authors:  Adorján Aszalós; Sándor Eckhardt
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

Review 2.  Molecular genetic abnormalities in the pathogenesis of human lung cancer.

Authors:  E Forgacs; S Zöchbauer-Müller; E Oláh; J D Minna
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

3.  Oxidant signaling for interleukin-13 gene expression in lung smooth muscle cells.

Authors:  Geetanjali Bansal; Chi-Ming Wong; Lingling Liu; Yuichiro J Suzuki
Journal:  Free Radic Biol Med       Date:  2012-02-25       Impact factor: 7.376

4.  Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo.

Authors:  E S Yi; H Lee; S Yin; P Piguet; I Sarosi; S Kaufmann; J Tarpley; N S Wang; T R Ulich
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

Review 5.  Platelet-derived growth factor in human brain tumors.

Authors:  M Kirsch; J C Wilson; P Black
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

6.  Assembly of fibronectin fibrils selectively attenuates platelet-derived growth factor-induced intracellular calcium release in fibroblasts.

Authors:  Christopher S Farrar; Denise C Hocking
Journal:  J Biol Chem       Date:  2018-10-15       Impact factor: 5.157

7.  Immunohistochemical overexpression of platelet-derived growth factor receptor-beta (PDGFR-β) is associated with PDGFRB gene copy number gain in sarcomatoid non-small-cell lung cancer.

Authors:  Anne S Tsao; Wei Wei; Elisabetta Kuhn; Loreto Spencer; Luisa M Solis; Milind Suraokar; J Jack Lee; Waun Ki Hong; Ignacio I Wistuba
Journal:  Clin Lung Cancer       Date:  2011-05-17       Impact factor: 4.785

8.  Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.

Authors:  E Buchdunger; J Zimmermann; H Mett; T Meyer; M Müller; U Regenass; N B Lydon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells.

Authors:  Marion T Weigel; Linda Dahmke; Christian Schem; Dirk O Bauerschlag; Katrin Weber; Peter Niehoff; Maret Bauer; Alexander Strauss; Walter Jonat; Nicolai Maass; Christoph Mundhenke
Journal:  BMC Cancer       Date:  2010-08-09       Impact factor: 4.430

10.  Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.

Authors:  A McGarry Houghton; Danuta M Rzymkiewicz; Hongbin Ji; Alyssa D Gregory; Eduardo E Egea; Heather E Metz; Donna B Stolz; Stephanie R Land; Luiz A Marconcini; Corrine R Kliment; Kimberly M Jenkins; Keith A Beaulieu; Majd Mouded; Stuart J Frank; Kwok K Wong; Steven D Shapiro
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.